Hepatocellular carcinoma (HCC) treatment faces dual challenges: resistance to targeted therapy and low response rates ...
Study design, patient eligibility and treatment This was a phase 1, first-in-human, open-label, nonrandomized, dose-escalation ...
Robert, C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat. Commun. 11, 3801 (2020). ...
Andersen, B. M. et al. Barcoded viral tracing identifies immunosuppressive astrocyte–glioma interactions. Nature 644, 1097–1106 ...
An antibody targeting the membrane-proximal epitope of AXL has enhanced antitumor efficacy To explore the ...
Jerne, N. K. Towards a network theory of the immune system. Ann. Immunol. 125C, 373–389 ...
Qin Y, Zheng X, Gao W, Wang B, Wu Y. Tumor microenvironment and immune-related therapies ...
Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol ...
Mao, Y. & Jiang, P. The crisscross between p53 and metabolism in cancer. Acta Biochim. ...
Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of ...